Cargando…

Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss

Adenosine A(1) receptors (A(1)AR) are well characterized for their role in cytoprotection. Previous studies have demonstrated the presence of these receptors in the cochlea where their activation were shown to suppress cisplatin-induced inflammatory response and the resulting ototoxicity. Inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheth, Sandeep, Sheehan, Kelly, Dhukhwa, Asmita, Al Aameri, Raheem F. H., Mamillapalli, Chaitanya, Mukherjea, Debashree, Rybak, Leonard P., Ramkumar, Vickram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606569/ https://www.ncbi.nlm.nih.gov/pubmed/31267026 http://dx.doi.org/10.1038/s41598-019-45964-9

Ejemplares similares

Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
por: Dhukhwa, Asmita, et al.
Publicado: (2021)

Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea
por: Bhatta, Puspanjali, et al.
Publicado: (2019)

The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018)

Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
por: Ramkumar, Vickram, et al.
Publicado: (2021)

Local Drug Delivery for Prevention of Hearing Loss
por: Rybak, Leonard P., et al.
Publicado: (2019)

Targeting Inflammatory Processes Mediated by TRPVI and TNF-α for Treating Noise-Induced Hearing Loss
por: Dhukhwa, Asmita, et al.
Publicado: (2019)

Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
por: Borse, Vikrant, et al.
Publicado: (2017)

Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
por: Sheth, Sandeep, et al.
Publicado: (2017)

Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol
por: Al Aameri, Raheem F. H., et al.
Publicado: (2017)

TRPV1: A Potential Drug Target for Treating Various Diseases
por: Brito, Rafael, et al.
Publicado: (2014)

Adenosine Receptors: Expression, Function and Regulation
por: Sheth, Sandeep, et al.
Publicado: (2014)

Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
por: Sheth, Sandeep, et al.
Publicado: (2012)

Ototoxicity of Non-aminoglycoside Antibiotics
por: Rybak, Leonard P., et al.
Publicado: (2021)

Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity
por: Al Aameri, Raheem F. H., et al.
Publicado: (2023)

Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation
por: Kaur, T, et al.
Publicado: (2011)

Cisplatin resistance reversal by disulfiram and caffeine
por: Kadia, Ashish R., et al.
Publicado: (2016)

Administration of Caffeine in Alternate Forms
por: Wickham, Kate A., et al.
Publicado: (2018)

The effect of caffeine on cisplatin-induced apoptosis of lung cancer cells
por: Wang, Gan, et al.
Publicado: (2015)

Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia
por: Trychta, Kathleen A., et al.
Publicado: (2022)

Caffeine exacerbates seizure-induced death via postictal hypoxia
por: George, Antis G., et al.
Publicado: (2023)

Achalasia in a Patient with Polyglandular Autoimmune Syndrome Type II
por: Amr, Bashar S., et al.
Publicado: (2015)

Caffeine administration does not alter salivary α-amylase activity in young male daily caffeine consumers
por: Klein, Laura Cousino, et al.
Publicado: (2014)

Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo
por: Abe, Kensaku, et al.
Publicado: (2019)

Maternal Caffeine Consumption and Its Impact on the Fetus: A Review
por: Lakin, Hunter, et al.
Publicado: (2023)

The impacts of caffeine administration, expectancies, and related stimuli on coffee craving, withdrawal, and self-administration
por: Shephard, Aaron, et al.
Publicado: (2021)

Heme-Mimetic Potential of Iron Conjugated Pheophytin-I in Attenuating Oxidative Stress-Induced Cellular and Vascular Toxicity
por: Das, Debashree, et al.
Publicado: (2022)

Effects of Transpulmonary Administration of Caffeine on Brain Activity in Healthy Men
por: Ueda, Kazutaka, et al.
Publicado: (2019)

Simultaneous administration of cocaine and caffeine dysregulates HCN and T-type channels
por: Rivero-Echeto, María Celeste, et al.
Publicado: (2020)

Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice
por: Tsuji, Takumi, et al.
Publicado: (2022)

Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
por: Long, Yanjun, et al.
Publicado: (2017)

Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin
por: Chirtes, Felician, et al.
Publicado: (2014)

Adiponectin deficiency exacerbates age-related hearing impairment
por: Tanigawa, T, et al.
Publicado: (2014)

Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022)

Urine caffeine metabolites and hearing threshold shifts in US adults: a cross-sectional study
por: Long, Lili, et al.
Publicado: (2021)

Acute Pericarditis as a Presentation of Adrenal Insufficiency
por: Manthri, Sukesh, et al.
Publicado: (2018)

Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
por: Lee, Chang Ho, et al.
Publicado: (2020)

No Enhancement of 24-Hour Visuomotor Skill Retention by Post-Practice Caffeine Administration
por: Hussain, Sara J., et al.
Publicado: (2015)

Protective Effects of Early Caffeine Administration in Hyperoxia-Induced Neurotoxicity in the Juvenile Rat
por: Heise, Julia, et al.
Publicado: (2023)

Growth Inhibition and Differentiation of Murine Melanoma B16‐BL6 Cells Caused by the Combination of Cisplatin and Caffeine
por: Tsuchiya, Hiroyuki, et al.
Publicado: (1989)

Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis
por: Bandaru, Sindhura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_brqpv4mun0nmtfiimhq51f26e8